Claims for Patent: 10,933,061
✉ Email this page to a colleague
Summary for Patent: 10,933,061
| Title: | Pyrvinium pamoate therapies and methods of use |
| Abstract: | The disclosure relates to a method of treating cancer by administering to the subject a therapeutically effective amount of a composition comprising pyrvinium pamoate, optionally in combination with at least one additional therapeutic agent or modality. |
| Inventor(s): | Arline Katherine, Barber Jamie Dempsey, Siders William M., Kaplan Johanne |
| Assignee: | Shepherd Therapeutics, Inc. |
| Application Number: | US16229783 |
| Patent Claims: |
Details for Patent 10,933,061
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | ⤷ Get Started Free | 2038-12-21 |
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | June 21, 1989 | ⤷ Get Started Free | 2038-12-21 |
| Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | June 04, 1986 | ⤷ Get Started Free | 2038-12-21 |
| Iovance Biotherapeutics Manufacturing Llc | PROLEUKIN | aldesleukin | For Injection | 103293 | May 05, 1992 | ⤷ Get Started Free | 2038-12-21 |
| Amgen Inc. | NEUPOGEN | filgrastim | Injection | 103353 | February 20, 1991 | ⤷ Get Started Free | 2038-12-21 |
| Amgen Inc. | NEUPOGEN | filgrastim | Injection | 103353 | June 28, 2000 | ⤷ Get Started Free | 2038-12-21 |
| Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | March 05, 1991 | ⤷ Get Started Free | 2038-12-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch